18-Apr-2024
No headlines found.
No press releases found.
No news found.
The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.
Direxion Daily S&P Biotech Bull 3X trades on the ARCA stock market under the symbol LABU.
As of April 18, 2024, LABU stock price declined to $88.04 with 2,520,028 million shares trading.
LABU has a beta of 3.94, meaning it tends to be more sensitive to market movements. LABU has a correlation of 0.33 to the broad based SPY ETF.
LABU has a market cap of $891.36 million. This is considered a Small Cap stock.
In the last 3 years, LABU stock traded as high as $1,722.96 and as low as $48.40.
LABU has underperformed the market in the last year with a price return of -23.5% while the SPY ETF gained +22.2%. LABU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -20.7% and -20.2%, respectively, while the SPY returned +5.2% and -2.6%, respectively.
LABU support price is $86.87 and resistance is $97.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABU stock will trade within this expected range on the day.